Abraham G Hsieh, MD
Otolaryngology · Walnut Creek
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 10
- 2 carriers
- Offices
- 4
Offices
4 locations · University Healthcare Alliance · 334 clinicians in this group
Hospitals listed: John Muir Medical Center - Concord Campus · John Muir Medical Center - Walnut Creek Campus · Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
10 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Hsieh’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
10 of 10 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A44211 · Current
Licensed to practise in California · since 1987 · expires 2027-04-30 · Tufts University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
4 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- John Muir Medical Center - Concord CampusConcord, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of John Muir Health, which runs 3 hospitalsPatients rate it 3 of 5 · 77% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.235, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.675, Oct 2024 – Sep 2025
- John Muir Medical Center - Walnut Creek CampusWalnut Creek, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of John Muir Health, which runs 3 hospitalsPatients rate it 3 of 5 · 77% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — Abdominopelvic accidental puncture or laceration rate: 2.01 (1.17 to 2.85) · 2,206 cases, Jul 2022 – Jun 2024Worse than the national rate — Death rate among surgical inpatients with serious treatable complications: 222.42 (177.82 to 267.02) · 120 cases, Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 1.4 (0.91 to 1.9) · 9,764 cases, Jul 2022 – Jun 2024Worse than the national rate — SSI - Colon Surgery: 2.734, Oct 2024 – Sep 2025Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.536, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.341, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.455, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.245, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for John Muir Medical Center - Concord Campus
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 0 better, 7 the same, 0 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.235 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.675 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.11 (0.21 to 2) · 1,612 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.77 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 184.13 (136.65 to 231.6) · 86 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.2 · 175 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.6 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.4 · 172 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8 · 537 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.5 · 434 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 13 · 215 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 3,208 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.32 (0.13 to 0.51) · 7,626 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.04 to 0.41) · 8,660 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.1 (1.29 to 4.91) · 2,723 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.21 (0 to 2.51) · 1,208 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3 (1.7 to 4.3) · 2,355 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.77 (3.24 to 12.3) · 1,216 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.43 (0.43 to 6.43) · 1,253 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.93 (0.47 to 3.4) · 388 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.14 (0.58 to 1.69) · 6,288 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.1 · 263 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.636 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.254 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.904 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.5 · 312 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.1 · 768 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -6.8 · 295 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.1 · 648 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 31.1 · 433 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 504 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.7 (5.1 to 8.8) · 476 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.9 (10.5 to 15.7) · 476 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 250 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 8.8 · 154 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.7 · 186 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (9.9 to 17.9) · 192 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.2) · 546 cases | No different | Jan 2024 – Dec 2024 |
What patients said (521 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
See every measure and the patient survey for John Muir Medical Center - Walnut Creek Campus
Behind the star rating — Deaths: 3 better, 2 the same, 2 worse of 7 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 3 better, 5 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 2.01 (1.17 to 2.85) · 2,206 cases | Worse | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 222.42 (177.82 to 267.02) · 120 cases | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.4 (0.91 to 1.9) · 9,764 cases | Worse | Jul 2022 – Jun 2024 |
| SSI - Colon SurgeryInfections | 2.734 | Worse | Oct 2024 – Sep 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.536 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.341 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.455 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.245 | Better | Oct 2024 – Sep 2025 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.14 (0.87 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 131 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 148 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 695 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.5 · 827 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 14.1 · 509 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 4,483 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.35 (0.18 to 0.53) · 11,630 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.05 to 0.39) · 11,793 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.33 (1.69 to 4.96) · 3,268 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.37 (0 to 2.94) · 1,631 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.76 (1.43 to 4.09) · 3,066 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.12 (0.22 to 12.02) · 1,580 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.43 (1.21 to 7.64) · 1,594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.82 (0.4 to 3.24) · 685 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 615 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 1.88 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.7 · 93 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 729 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -30.1 · 91 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13 · 736 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 34.8 · 842 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.7 · 818 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.3 (3.3 to 8.4) · 28 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (7.2 to 15.5) · 28 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 584 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.4 · 139 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.9) · 222 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 321 cases | No different | Jan 2024 – Dec 2024 |
What patients said (758 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 69% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$210,540
Medicare paid this office $210,540 for 811 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 252 | $38,425 | $116 |
| Short return visit (20+ min) | 342 | $37,441 | $81 |
| New patient visit (45+ min) | 194 | $26,870 | $139 |
| Diagnostic exam of nasal passages using an endoscope | 110 | $25,784 | $179 |
| New patient visit (30+ min) | 217 | $19,816 | $91 |
See all 11 services
| Return visit (30+ min) | 252 | $38,425 | $116 |
| Short return visit (20+ min) | 342 | $37,441 | $81 |
| New patient visit (45+ min) | 194 | $26,870 | $139 |
| Diagnostic exam of nasal passages using an endoscope | 110 | $25,784 | $179 |
| New patient visit (30+ min) | 217 | $19,816 | $91 |
| Diagnostic exam of voice box using a flexible endoscope | 120 | $15,917 | $122 |
| Removal of impacted ear wax | 305 | $15,107 | $40 |
| Simple control of nose bleed | 27 | $4,324 | $139 |
| Short return visit | 41 | $2,377 | $52 |
| Repositioning exercises of head for treatment of dizziness, each day | 25 | $1,072 | $37 |
| New patient visit (15+ min) | 16 | $846 | $53 |
Who their Medicare patients are
811 Original Medicare patients in 2024. Average age 77 · Under 65 2% · 85 and older 21% · Women 58% · Also on Medicaid 8% · Health risk score 1.13. At or below the middle of the specialty; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 71% · Coronary heart disease 24% · Chronic kidney disease 24% · Atrial fibrillation 20% · Cancer 19% · Depression 19% · Diabetes 18% · COPD 14% · Heart failure 11% · Stroke 9% · Dementia 5%.
The office billed $1,080,192, Medicare allowed $287,104 and paid $210,540; for 2,216 services of 54 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 811 | 2,216 | 77 | 1.13 | $1,080,192 | $210,540 |
| 2023 | 838 | 2,103 | 76 | 1.09 | $903,561 | $187,350 |
| 2022 | 796 | 2,159 | 76 | 1.04 | $936,701 | $189,972 |
| 2021 | 665 | 1,802 | 76 | 1.01 | $820,741 | $170,151 |
| 2020 | 498 | 1,406 | 76 | 1.12 | $527,738 | $103,738 |
| 2019 | 718 | 2,291 | 76 | 1.08 | $728,334 | $147,615 |
| 2018 | 590 | 1,659 | 76 | 1.13 | $568,655 | $123,707 |
| 2017 | 518 | 1,737 | 76 | 1.11 | $498,216 | $121,094 |
| 2016 | 550 | 1,495 | 75 | 1.06 | $438,015 | $115,250 |
| 2015 | 502 | 1,741 | 75 | 1.10 | $203,196 | $111,971 |
| 2014 | 436 | 1,881 | 75 | 0.99 | $191,528 | $101,497 |
| 2013 | 421 | 1,893 | 74 | 1.02 | $176,384 | $97,063 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Short return visit (20+ min) | 334 | $34,350 | $78 |
| Return visit (30+ min) | 198 | $28,905 | $114 |
| New patient visit (45+ min) | 185 | $26,777 | $145 |
| New patient visit (30+ min) | 270 | $25,896 | $96 |
| Diagnostic exam of nasal passages using an endoscope | 103 | $21,803 | $180 |
| Diagnostic exam of voice box using a flexible endoscope | 101 | $13,642 | $124 |
| Removal of impacted ear wax | 281 | $13,436 | $40 |
| Short return visit | 38 | $2,449 | $51 |
| Simple control of nose bleed | 12 | $2,003 | $143 |
| Removal of foreign body in ear canal | 19 | $1,652 | $87 |
| New patient visit (15+ min) | 16 | $913 | $57 |
| Repositioning exercises of head for treatment of dizziness, each day | 11 | $443 | $40 |
2022: 11 services
| Short return visit (20+ min) | 300 | $31,207 | $79 |
| Return visit (30+ min) | 203 | $30,562 | $115 |
| New patient visit (45+ min) | 192 | $28,903 | $151 |
| New patient visit (30+ min) | 254 | $24,051 | $95 |
| Diagnostic exam of nasal passages using an endoscope | 82 | $16,586 | $171 |
| Diagnostic exam of voice box using a flexible endoscope | 125 | $16,334 | $123 |
| Removal of impacted ear wax | 249 | $12,041 | $40 |
| Simple control of nose bleed | 21 | $3,563 | $148 |
| Removal of foreign body in ear canal | 29 | $2,724 | $91 |
| Short return visit | 42 | $2,189 | $48 |
| Repositioning exercises of head for treatment of dizziness, each day | 17 | $657 | $35 |
2021: 11 services
| Short return visit (20+ min) | 309 | $34,730 | $82 |
| Return visit (30+ min) | 149 | $22,954 | $123 |
| New patient visit (30+ min) | 222 | $21,158 | $95 |
| New patient visit (45+ min) | 115 | $17,952 | $156 |
| Diagnostic exam of nasal passages using an endoscope | 60 | $15,441 | $186 |
| Removal of impacted ear wax | 280 | $12,564 | $38 |
| Diagnostic exam of voice box using a flexible endoscope | 73 | $9,982 | $122 |
| Biopsy or removal of nasal polyp or tissue using an endoscope | 11 | $8,866 | $369 |
| Simple control of nose bleed | 26 | $4,368 | $136 |
| Short return visit | 41 | $2,385 | $48 |
| Repositioning exercises of head for treatment of dizziness, each day | 14 | $522 | $37 |
2020: 10 services
| Short return visit (20+ min) | 283 | $31,747 | $65 |
| New patient visit (30+ min) | 214 | $19,611 | $92 |
| Removal of impacted ear wax | 197 | $9,655 | $40 |
| Diagnostic exam of nasal passages using an endoscope | 36 | $7,819 | $182 |
| Diagnostic exam of voice box using a flexible endoscope | 45 | $5,533 | $111 |
| New patient visit (45+ min) | 28 | $4,266 | $152 |
| Return visit (30+ min) | 24 | $2,549 | $106 |
| Simple control of nose bleed | 15 | $2,427 | $152 |
| New patient visit (15+ min) | 13 | $854 | $66 |
| Repositioning exercises of head for treatment of dizziness, each day | 14 | $551 | $37 |
2019: 9 services
| Short return visit (20+ min) | 373 | $41,380 | $66 |
| New patient visit (30+ min) | 395 | $36,989 | $94 |
| Diagnostic exam of nasal passages using an endoscope | 85 | $19,643 | $187 |
| Removal of impacted ear wax | 240 | $10,996 | $38 |
| Diagnostic exam of voice box using a flexible endoscope | 86 | $10,340 | $101 |
| Simple control of nose bleed | 29 | $4,385 | $122 |
| Return visit (30+ min) | 34 | $3,313 | $95 |
| Repositioning exercises of head for treatment of dizziness, each day | 15 | $866 | $41 |
| Short return visit | 16 | $615 | $38 |
2018: 10 services
| Short return visit (20+ min) | 280 | $32,208 | $65 |
| New patient visit (30+ min) | 315 | $29,696 | $94 |
| Diagnostic exam of nasal passages using an endoscope | 75 | $18,532 | $201 |
| Removal of impacted ear wax | 211 | $9,743 | $39 |
| Diagnostic exam of voice box using a flexible endoscope | 81 | $9,355 | $101 |
| Return visit (30+ min) | 61 | $6,336 | $88 |
| Simple control of nose bleed | 18 | $2,782 | $111 |
| New patient visit (45+ min) | 12 | $1,618 | $135 |
| Short return visit | 20 | $839 | $42 |
| Repositioning exercises of head for treatment of dizziness, each day | 19 | $674 | $35 |
2017: 12 services
| Short return visit (20+ min) | 233 | $24,798 | $64 |
| New patient visit (30+ min) | 259 | $23,518 | $91 |
| Return visit (30+ min) | 151 | $19,689 | $93 |
| Diagnostic exam of nasal passages using an endoscope | 61 | $14,867 | $188 |
| Diagnostic exam of voice box using a flexible endoscope | 68 | $7,875 | $100 |
| Removal of impacted ear wax | 152 | $7,394 | $40 |
| New patient visit (45+ min) | 23 | $3,255 | $142 |
| Incision of eardrum with placement of eardrum tube under general anesthesia | 13 | $1,945 | $139 |
| Simple control of nose bleed | 16 | $1,497 | $71 |
| Comprehensive hearing and speech recognition test | 17 | $619 | $34 |
| Repositioning exercises of head for treatment of dizziness, each day | 13 | $541 | $36 |
| Test to assess middle ear function | 18 | $234 | $12 |
2016: 9 services
| Return visit (30+ min) | 284 | $38,177 | $86 |
| New patient visit (30+ min) | 263 | $23,197 | $88 |
| Diagnostic exam of nasal passages using an endoscope | 52 | $13,667 | $192 |
| Diagnostic exam of voice box using a flexible endoscope | 70 | $9,770 | $100 |
| Removal of impacted ear wax | 141 | $7,215 | $41 |
| Short return visit (20+ min) | 78 | $5,984 | $61 |
| Long return visit (40+ min) | 16 | $2,318 | $116 |
| Simple control of nose bleed | 18 | $1,779 | $81 |
| Comprehensive hearing and speech recognition test | 13 | $387 | $30 |
2015: 9 services
| Return visit (30+ min) | 270 | $38,227 | $88 |
| New patient visit (30+ min) | 230 | $18,988 | $83 |
| Diagnostic exam of nasal passages using an endoscope | 51 | $11,448 | $197 |
| Diagnostic exam of voice box using a flexible endoscope | 79 | $10,317 | $103 |
| Removal of impacted ear wax | 102 | $4,569 | $40 |
| New patient visit (45+ min) | 29 | $4,110 | $142 |
| Short return visit (20+ min) | 43 | $2,679 | $57 |
| Simple control of nose bleed | 18 | $2,039 | $85 |
| Long return visit (40+ min) | 15 | $1,834 | $115 |
2014: 10 services
| Return visit (30+ min) | 210 | $29,904 | $89 |
| New patient visit (30+ min) | 184 | $15,301 | $83 |
| Diagnostic exam of nasal passages using an endoscope | 35 | $9,606 | $200 |
| Diagnostic exam of voice box using a flexible endoscope | 59 | $7,376 | $104 |
| New patient visit (45+ min) | 34 | $4,256 | $125 |
| Removal of impacted ear wax | 82 | $3,805 | $41 |
| Short return visit (20+ min) | 45 | $3,042 | $58 |
| Long return visit (40+ min) | 18 | $2,185 | $121 |
| Simple control of nose bleed | 13 | $1,194 | $85 |
| Repositioning exercises of head for treatment of dizziness, each day | 12 | $496 | $38 |
2013: 12 services
| Return visit (30+ min) | 188 | $29,162 | $87 |
| New patient visit (30+ min) | 123 | $10,066 | $82 |
| Diagnostic exam of nasal passages using an endoscope | 33 | $8,071 | $202 |
| Diagnostic exam of voice box using a flexible endoscope | 62 | $7,873 | $105 |
| New patient visit (45+ min) | 50 | $6,576 | $132 |
| Short return visit (20+ min) | 62 | $3,446 | $51 |
| Removal of impacted ear wax | 73 | $3,177 | $41 |
| Incision of eardrum with insertion of eardrum tube under local or topical anesthesia | 14 | $3,116 | $195 |
| Long return visit (40+ min) | 16 | $1,845 | $115 |
| Simple control of nose bleed | 15 | $1,431 | $84 |
| New patient visit (15+ min) | 22 | $1,098 | $50 |
| Short return visit | 16 | $561 | $31 |
Drugs they prescribed that Part D paid
$44,811
Pharmacies billed $44,811 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
974 generic and 27 brand-name prescriptions · $44,811 in drug cost · 61 antibiotic prescriptions to 52 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Azelastine | 430 | $16,147 | $38 |
| Xhance | 20 | $12,360 | $618 |
| Ipratropium | 147 | $6,414 | $44 |
| Ofloxacin | 35 | $1,826 | $52 |
| Fluticasone Propionate | 92 | $1,293 | $14 |
See all 11 drugs
| Azelastine | 430 | $16,147 | $38 |
| Xhance | 20 | $12,360 | $618 |
| Ipratropium | 147 | $6,414 | $44 |
| Ofloxacin | 35 | $1,826 | $52 |
| Fluticasone Propionate | 92 | $1,293 | $14 |
| Fluocinolone Acetonide Oil | 13 | $348 | $27 |
| Amoxicillin-Clavulanate Potass | 34 | $347 | $10 |
| Methylprednisolone | 44 | $318 | $7 |
| Montelukast | 32 | $306 | $10 |
| Triamterene-Hydrochlorothiazid | 25 | $175 | $7 |
| Gabapentin | 13 | $84 | $6 |
Year by year
| 2024 | 1,001 | 368 | None | 3% | $44,811 |
| 2023 | 764 | 313 | None | 3% | $35,035 |
| 2022 | 728 | 284 | None | 3% | $35,537 |
| 2021 | 597 | 231 | None | 5% | $27,329 |
| 2020 | 522 | 201 | None | 7% | $25,679 |
| 2019 | 465 | 211 | None | 6% | $21,996 |
| 2018 | 388 | 176 | None | 8% | $20,363 |
| 2017 | 407 | 172 | None | 13% | $18,933 |
| 2016 | 398 | 169 | None | 11% | $16,887 |
| 2015 | 400 | 161 | None | 13% | $22,326 |
| 2014 | 325 | 134 | 4% (12) | 26% | $23,017 |
| 2013 | 360 | 140 | 6% (20) | 29% | $27,317 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 11 drugs
| Azelastine | 298 | $13,453 | $45 |
| Ipratropium | 91 | $4,760 | $52 |
| Fluticasone Propionate | 101 | $2,371 | $23 |
| Ofloxacin | 28 | $2,368 | $85 |
| Neomycin-Polymyxin-Hc | 11 | $794 | $72 |
| Gabapentin | 22 | $499 | $23 |
| Methylprednisolone | 37 | $422 | $11 |
| Amoxicillin-Clavulanate Potass | 18 | $166 | $9 |
| Montelukast | 19 | $159 | $8 |
| Triamterene-Hydrochlorothiazid | 14 | $119 | $9 |
| Doxycycline Hyclate | 16 | $76 | $5 |
2022: 12 drugs
| Azelastine | 253 | $12,289 | $49 |
| Xhance | 11 | $6,610 | $601 |
| Ipratropium | 70 | $3,323 | $47 |
| Ofloxacin | 28 | $2,605 | $93 |
| Fluticasone Propionate | 120 | $1,983 | $17 |
| Fluocinolone Acetonide Oil | 19 | $1,118 | $59 |
| Neomycin-Polymyxin-Hc | 14 | $870 | $62 |
| Montelukast | 32 | $469 | $15 |
| Methylprednisolone | 30 | $296 | $10 |
| Amoxicillin-Clavulanate Potass | 16 | $181 | $11 |
| Gabapentin | 16 | $102 | $6 |
| Doxycycline Hyclate | 12 | $44 | $4 |
2021: 13 drugs
| Azelastine | 187 | $7,115 | $38 |
| Ipratropium | 69 | $4,080 | $59 |
| Azelastine-Fluticasone | 14 | $3,605 | $258 |
| Ofloxacin | 26 | $1,588 | $61 |
| Fluticasone Propionate | 86 | $1,213 | $14 |
| Fluocinolone Acetonide Oil | 15 | $880 | $59 |
| Neomycin-Polymyxin-Hc | 12 | $782 | $65 |
| Triamcinolone Acetonide | 13 | $448 | $34 |
| Montelukast | 27 | $390 | $14 |
| Methylprednisolone | 19 | $192 | $10 |
| Amoxicillin-Clavulanate Potass | 15 | $187 | $12 |
| Gabapentin | 14 | $91 | $6 |
| Ciprofloxacin | 11 | $79 | $7 |
2020: 9 drugs
| Azelastine | 125 | $5,171 | $41 |
| Ipratropium | 51 | $4,587 | $90 |
| Ciprodex | 12 | $3,020 | $252 |
| Ofloxacin | 27 | $1,686 | $62 |
| Fluticasone Propionate | 86 | $1,437 | $17 |
| Montelukast | 19 | $279 | $15 |
| Gabapentin | 28 | $247 | $9 |
| Amoxicillin-Clavulanate Potass | 21 | $242 | $12 |
| Methylprednisolone | 24 | $229 | $10 |
2019: 8 drugs
| Azelastine | 138 | $6,121 | $44 |
| Ipratropium | 43 | $3,534 | $82 |
| Ofloxacin | 25 | $1,657 | $66 |
| Fluticasone Propionate | 87 | $1,175 | $14 |
| Neomycin-Polymyxin-Hc | 12 | $764 | $64 |
| Methylprednisolone | 20 | $240 | $12 |
| Amoxicillin-Clavulanate Potass | 15 | $196 | $13 |
| Gabapentin | 15 | $168 | $11 |
2018: 9 drugs
| Azelastine | 101 | $4,972 | $49 |
| Ciprodex | 11 | $2,481 | $226 |
| Ofloxacin | 17 | $2,140 | $126 |
| Ipratropium | 26 | $1,639 | $63 |
| Fluticasone Propionate | 83 | $1,220 | $15 |
| Neomycin-Polymyxin-Hc | 16 | $819 | $51 |
| Methylprednisolone | 17 | $209 | $12 |
| Amoxicillin-Clavulanate Potass | 13 | $127 | $10 |
| Pantoprazole | 11 | $122 | $11 |
2017: 8 drugs
| Azelastine | 83 | $3,560 | $43 |
| Ciprodex | 14 | $2,839 | $203 |
| Fluticasone Propionate | 98 | $1,285 | $13 |
| Ipratropium | 27 | $792 | $29 |
| Methylprednisolone | 20 | $241 | $12 |
| Montelukast | 19 | $235 | $12 |
| Amoxicillin-Clavulanate Potass | 16 | $204 | $13 |
| Ofloxacin | 14 | $196 | $14 |
2016: 6 drugs
| Azelastine | 97 | $6,254 | $64 |
| Fluticasone Propionate | 69 | $819 | $12 |
| Ipratropium | 25 | $646 | $26 |
| Montelukast | 24 | $306 | $13 |
| Methylprednisolone | 18 | $297 | $17 |
| Pantoprazole | 23 | $247 | $11 |
2015: 11 drugs
| Azelastine | 75 | $6,695 | $89 |
| Ciprodex | 17 | $2,945 | $173 |
| Fluticasone Propionate | 88 | $862 | $10 |
| Ofloxacin | 12 | $498 | $41 |
| Ipratropium | 20 | $444 | $22 |
| Montelukast | 26 | $382 | $15 |
| Methylprednisolone | 13 | $238 | $18 |
| Amoxicillin-Clavulanate Potass | 14 | $190 | $14 |
| Potassium Chloride | 11 | $135 | $12 |
| Pantoprazole | 15 | $134 | $9 |
| Hydrochlorothiazide | 11 | $77 | $7 |
2014: 9 drugs
| Azelastine | 55 | $4,885 | $89 |
| Nexium | 20 | $4,857 | $243 |
| Astepro | 14 | $1,825 | $130 |
| Fluticasone Propionate | 52 | $864 | $17 |
| Ipratropium | 15 | $392 | $26 |
| Methylprednisolone | 18 | $370 | $21 |
| Ofloxacin | 11 | $335 | $30 |
| Montelukast | 22 | $310 | $14 |
| Pantoprazole | 13 | $144 | $11 |
2013: 10 drugs
| Azelastine | 63 | $4,970 | $79 |
| Patanase | 16 | $2,975 | $186 |
| Ciprodex | 18 | $2,682 | $149 |
| Astepro | 17 | $2,350 | $138 |
| Montelukast | 19 | $1,580 | $83 |
| Fluticasone Propionate | 50 | $1,111 | $22 |
| Ipratropium | 18 | $645 | $36 |
| Amox Tr-Potassium Clavulanate | 16 | $428 | $27 |
| Clindamycin | 12 | $197 | $16 |
| Hydrocodone-Acetaminophen | 11 | $94 | $9 |
Money from drug and device companies
$438 in 2025
| 2025 | 5 | 9 | None | $438 |
| 2024 | 3 | 3 | None | $111 |
| 2023 | 2 | 2 | None | $167 |
| 2022 | 3 | 4 | None | $71 |
| 2021 | 9 | 18 | $37 | $383 |
| 2020 | 4 | 11 | None | $297 |
| 2019 | 2 | 4 | None | $80 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Integra LifeSciences | Acclarent Aera | $168 | 2 payments
|
| Optinose US | Xhance | $126 | 1 payment
|
| Smith+Nephew | Halo | $98 | 4 payments
|
| Paratek Pharmaceuticals | Xhance | $25 | 1 payment
|
| GlaxoSmithKline | Nucala | $22 | 1 payment
|
See all 9 published payments
| Smith+Nephew | Meals · 2025-12-16 | Halo | $18 |
| Paratek Pharmaceuticals | Meals · 2025-11-21 | Xhance | $25 |
| Smith+Nephew | Meals · 2025-11-20 | Halo | $16 |
| Integra LifeSciences | Meals · 2025-06-11 | Acclarent Aera | $26 |
| Integra LifeSciences | Meals · 2025-06-11 | Acclarent Aera | $143 |
| Smith+Nephew | Meals · 2025-05-28 | Halo | $38 |
| Optinose US | Meals · 2025-05-23 | Xhance | $126 |
| Smith+Nephew | Meals · 2025-04-14 | Halo | $26 |
| GlaxoSmithKline | Meals · 2025-03-19 | Nucala | $22 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $111
| Stryker | Audion Et Dilation System | $63 | 1 payment
|
| Regeneron Healthcare Solutions | Dupixent | $25 | 1 payment
|
| GlaxoSmithKline | Nucala | $23 | 1 payment
|
2023: $167
| Medtronic | Sinuva | $151 | 1 payment
|
| Optinose US | Xhance | $16 | 1 payment
|
2022: $71
| ALK-Abello | Grastek | $32 | 2 payments
|
| GlaxoSmithKline | Nucala | $23 | 1 payment
|
| Allergan | Vuity | $17 | 1 payment
|
2021: $383
| Intersect ENT | Sinuva | $98 | 2 payments
|
| Forte Bio-Pharma | Prolate | $48 | 1 payment
|
| Allergan | Restasis Multidose | $44 | 3 payments
|
| Optinose US | Xhance | $44 | 2 payments
|
| Itamar Medical | Watchpat | $37 | 1 payment
|
| Stryker | Scopis Ent | $37 | 2 payments
|
| Aerin Medical | Vivaer Stylus | $29 | 1 payment
|
| ALK-Abello | Otiprio | $25 | 2 payments
|
| GlaxoSmithKline | Nucala | $21 | 1 payment
|
2020: $297
| Allergan | Restasis | $132 | 8 payments
|
| Optinose US | Xhance | $128 | 1 payment
|
| Intersect ENT | Sinuva | $26 | 1 payment
|
| ALK-Abello | Otiprio | $12 | 1 payment
|
2019: $80
| Allergan | Lumigan | $41 | 3 payments
|
| Aerin Medical | Vivaer Rf Stylus | $39 | 1 payment
|
Professional record
- NPI
- 1679520076
- Licence
- CA A44211California A44211: Current · expires 2027-04-30
- Trained
- Tufts University School of Medicine, 1986
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Otolaryngology (207Y00000X)
- Mailing address
- 2623 Shadelands Dr Ste 1, Walnut Creek, CA, 94598
- NPI first listed
- 2006-05-30
- NPI last updated
- 2024-04-29
- NPI record certified
- 2024-04-29
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr, Stanford, CA, 94305 · 1776 Ygnacio Valley Rd, Walnut Creek, CA, 94598